Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 749,458 $ 629,725
Loans receivable, allowance for credit losses 90,426 61,408
Face amount of subordinated debentures 126,800 126,800
Unamortized discount and debt issuance costs $ 7,828 $ 8,423
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 33,560,801 33,475,402
Common stock outstanding (shares) 30,717,835 30,799,624
Accumulated other comprehensive income (loss), tax benefit (expense) $ 1,247 $ 1,370
Treasury stock (shares) 2,842,966 2,675,778